SCHRODER INVESTMENT MANAGEMENT GROUP - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 173 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$24,000
-4.0%
3,0000.0%0.00%
Q1 2015$25,000
+19.0%
3,0000.0%0.00%
Q4 2014$21,000
-99.9%
3,0000.0%0.00%
Q3 2014$16,200,000
-15.2%
3,0000.0%0.00%
Q2 2014$19,110,000
-21.0%
3,0000.0%0.00%
Q1 2014$24,180,0003,0000.00%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$175,916,00040.51%
Consonance Capital Management LP 8,695,742$119,045,00011.46%
Tamarack Advisers, LP 3,700,000$49,358,0007.76%
Opaleye Management Inc. 1,045,000$14,306,0007.49%
Granite Point Capital Management, L.P. 457,415$6,262,0002.44%
Redmile Group, LLC 2,138,471$29,276,0002.33%
IRONWOOD INVESTMENT MANAGEMENT LLC 206,010$2,820,0002.17%
Palo Alto Investors LP 2,587,617$35,424,0002.06%
PRICE MICHAEL F 940,000$12,869,0001.71%
HighVista Strategies LLC 638,086$8,735,0001.62%
View complete list of ARIAD PHARMACEUTICALS INC shareholders